Recently I was wandering through the local market, and found myself in front of a stall selling therapeutic magnets. I …
GlaxoSmithKline will acquire a Seattle-based biotech that manufactures a key component in many of the candidates in its vaccine pipeline, …
Sometimes it is hard to see where the fun lies in running a biotechnology company. Discounting the obvious success stories …
Flexibility and constant adjustment are necessary to survive one of the toughest times in the history of the industry.There have …
Attend any networking conference bringing together fledgling biotechnology companies and investors, whether financial or industry, and you will repeatedly hear …
The biotech sector is facing a paradox. Traditionally, the strength of the sector has been based on the ability of …
The turn of the century has witnessed a period of intense uncertainty and instability within the pharma sector. After decades …

